Tag: biomedical

  • Study: Records Database Offers Clinical Trial Savings

    3 December 2015. A cost-benefit analysis shows pharmaceutical companies could reap sizable savings in their planning and conduct of clinical trials if they made regular use of a European electronic health records database. The study, led by Data Mining Institute in Geneva, Switzerland with co-authors from several pharmaceutical companies, appears in the January 2016 issue…

  • Antibodies Reduce Whooping Cough Severity, Infections

    3 December 2015. Two engineered antibodies were shown in tests with lab animals to reduce the severity of whooping cough symptoms and white blood cell counts indicating infection. The team from the protein engineering lab of Jennifer Maynard at University of Texas in Austin and Synthetic Biologics, a biotechnology company in Rockville, Maryland, published its…

  • Chlamydia Vaccine Shown Working in Lab Tests

    2 December 2015. An experimental vaccine to prevent chlamydia was shown in tests with lab mice to prevent pelvic inflammation and clear bacteria more than mice not receiving the vaccine. The vaccine, given through the nose, is made by NanoBio Corp., a biopharmaceutical company in Ann Arbor, Michigan. Chlamydia is a sexually transmitted disease that…

  • CRISPR-Cas9 Gene Editing Made More Accurate

    1 December 2015. Medical and engineering researchers enhanced emerging CRISPR-Cas9 genome editing techniques, reducing erroneous off-target edits with an engineered enzyme. The team from the Broad Institute, a medical research center at Harvard University and Massachusetts Institute of Technology, and the McGovern Institute for Brain Research at MIT, published its findings today online in Science…

  • Implanted Sensor to Measure Blood Sugar in Development

    1 December 2015. An engineering group at University of Texas in Arlington is developing a system for people with diabetes to measure their blood glucose levels without taking repeated blood drops throughout the day. The work in the lab of biomaterials professor Kyungsuk Yum is funded by a $100,00 grant from the Texas Medical Research Collaborative.…

  • FDA Approves Antibody Treatment for Lung Cancer

    25 November 2015. U.S. Food and Drug Administration yesterday approved necitumumab, an engineered antibody to treat squamous non-small cell lung cancer that spreads to other parts of the body. Necitumumab is marketed under the brand name Portrazza by Eli Lilly and Company. Worldwide, lung cancer causes some 1.6 million deaths, according to World Health Organization. Non-small cell lung…

  • Antibodies to Treat Staph Infections in Early Trial

    24 November 2015. A study testing the safety of antibodies to prevent and treat Staphylococcus aureus infections, including those contracted in hospitals, is underway in Vienna, Austria. The clinical trial is evaluating an experimental biologic drug for the prevention and treatment of S. aureus or staph infections made by Arsanis Biosciences, a biotechnology company in…

  • Trial Tests Vibrating Mattress to Prevent Infant Apnea

    24 November 2015. A mattress that provides occasional mild vibrations was shown in a clinical trial to prevent episodes of interrupted breathing in preterm babies, a condition known as infant apnea. Results of the study testing the device, developed at the Wyss Institute, a biomedical engineering research center at Harvard University, were reported yesterday in…

  • Chip Device Removes Nanoparticles from Plasma

    23 November 2015. A team from University of California in San Diego used a miniature electronic chip to quickly separate nanoparticles for delivering drugs from blood plasma. The process, with a technology developed in the engineering lab of Michael Heller at UC-San Diego and licensed to a spin-off company from the university, is described in…

  • FDA Approves Nasal Spray for Opioid Overdose

    20 November 2015. The U.S. Food and Drug Administration this week approved the first formulation of a current drug to treat opioid overdose in nasal spray form. The Narcan nasal spray is made by Adapt Pharma Ltd., a company headquartered in Dublin, Ireland. Opioids work by reducing the intensity of pain signals to the brain, particularly…